Home Applications 209525 Application 209525
Type ANDA
Sponsor TEVA PHARMS USA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ICOSAPENT ETHYL ICOSAPENT ETHYL CAPSULE;ORAL 500MG No No 002 ICOSAPENT ETHYL ICOSAPENT ETHYL CAPSULE;ORAL 1G No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209525-001 ICOSAPENT ETHYL ICOSAPENT ETHYL 500MG CAPSULE / ORAL AB 2020-09-11 A209525-002 ICOSAPENT ETHYL ICOSAPENT ETHYL 1GM CAPSULE / ORAL AB 2020-09-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A209525-001 ICOSAPENT ETHYL 500MG CAPSULE / ORAL AB 2020-09-11 a50c72e98297…2026-08-01 22:54:32 2026-06 A209525-002 ICOSAPENT ETHYL 1GM CAPSULE / ORAL AB 2020-09-11 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 A209525-001 AB 1 a50c72e98297…2026-08-01 22:54:32 2026-06 A209525-002 AB 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0480-0126 Icosapent Ethyl Icosapent Ethyl Teva Pharmaceuticals, Inc. ANDA Current 0480-0126 Icosapent Ethyl Icosapent Ethyl Teva Pharmaceuticals, Inc. ANDA Current 0480-0127 Icosapent Ethyl Icosapent Ethyl Teva Pharmaceuticals, Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 65089 ORIG 2020-10-30 64401 ORIG 2020-08-24